Interleukin-17 and acute coronary syndrome
- PMID: 23897784
- PMCID: PMC3735965
- DOI: 10.1631/jzus.BQICC701
Interleukin-17 and acute coronary syndrome
Abstract
Inflammation plays an important role in atherosclerosis, which is also crucial for acute coronary syndrome (ACS). Recent studies have revealed that interleukin (IL)-17, which was regarded as a pro-inflammatory cytokine, has a dual function in the progress of ACS. In this review, we sum up both experimental and clinical studies on the relevance of IL-17 to atherosclerosis and its complications, and summarize the research progress on the effect of IL-17 on the atherosclerotic plaque stability and ACS onset. Although the studies are controversial and the mechanism remains unclear, we highlight the knowledge of the role of IL-17 in ACS and elucidate its potential mechanism.
Conflict of interest statement
This article does not contain any studies with human or animal subjects performed by any of the authors.
Similar articles
-
Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.Curr Atheroscler Rep. 2013 Jun;15(6):327. doi: 10.1007/s11883-013-0327-7. Curr Atheroscler Rep. 2013. PMID: 23636864 Review.
-
Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?Thromb Haemost. 2012 Sep;108(3):443-56. doi: 10.1160/TH12-05-0341. Epub 2012 Aug 7. Thromb Haemost. 2012. PMID: 22872109 Review.
-
Serum complement C1q level is associated with acute coronary syndrome.Mol Immunol. 2020 Apr;120:130-135. doi: 10.1016/j.molimm.2020.02.012. Epub 2020 Feb 28. Mol Immunol. 2020. PMID: 32120180
-
The Two Faces of Interleukin-17A in Atherosclerosis.Curr Drug Targets. 2017;18(7):863-873. doi: 10.2174/1389450117666161229142155. Curr Drug Targets. 2017. PMID: 28034277 Review.
-
The pleiotropic role of interleukin-17 in atherosclerosis.Biomed Pharmacother. 2018 Oct;106:1412-1418. doi: 10.1016/j.biopha.2018.07.110. Epub 2018 Jul 24. Biomed Pharmacother. 2018. PMID: 30119214 Review.
Cited by
-
Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.J Clin Med. 2024 Aug 27;13(17):5088. doi: 10.3390/jcm13175088. J Clin Med. 2024. PMID: 39274304 Free PMC article. Review.
-
Identification of key gene modules and pathways of human platelet transcriptome in acute myocardial infarction patients through co-expression network.Am J Transl Res. 2021 Apr 15;13(4):3890-3905. eCollection 2021. Am J Transl Res. 2021. PMID: 34017580 Free PMC article.
-
Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome.Psychosom Med. 2017 Apr;79(3):318-326. doi: 10.1097/PSY.0000000000000404. Psychosom Med. 2017. PMID: 27749683 Free PMC article. Clinical Trial.
-
MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis.BMC Cardiovasc Disord. 2020 Jun 19;20(1):300. doi: 10.1186/s12872-020-01564-4. BMC Cardiovasc Disord. 2020. PMID: 32560699 Free PMC article.
-
Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction.Basic Res Cardiol. 2018 Dec 6;114(1):4. doi: 10.1007/s00395-018-0712-z. Basic Res Cardiol. 2018. PMID: 30523422 Free PMC article. Review.
References
-
- Ávalos AM, Apablaza FA, Quiroz M, Toledo V, Peño JP, Michea L, Irarrázabal CE, Carrión FA, Figueroa FE. IL-17A levels increase in the infarcted region of the left ventricle in a rat model of myocardial infarction. Biol Res. 2012;45(2):193–200. - PubMed
-
- Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res. 2010;106(10):1646–1655. doi: 10.1161/CIRCRESAHA.109.213157. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources